APO RESEARCH · REPORT
Drug Delivery Devices
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
Product & engineering
Understand the product.
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
Selected research
Industry Growth & Trends
Global Drug Delivery Devices Industry Growth and Trends Forecast to 2032
Market perspective
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
According to APO Research, the global Drug Delivery Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Drug Delivery Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Drug Delivery Devices market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drug Delivery Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drug Delivery Devices.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Drug Delivery Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Drug Delivery Devices Market by Company
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
Drug Delivery Devices Segment by Type
Injection Type
Mucosal Type
Implanted Type
Others Type
Drug Delivery Devices Segment by Application
Pharmaceutical Companies
Hospitals
Clinics
Other
Drug Delivery Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Delivery Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drug Delivery Devices companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection Type
- Mucosal Type
- Implanted Type
- Others Type
Applications
- Pharmaceutical Companies
- Hospitals
- Clinics
- Other
Companies covered
- Cipla
- Baxter International
- Nipro Corporation
- Roche
- Boehringer Ingelheim
- Allergan
- 3M
- BD
- Catalent
- Valeant Pharmaceuticals
- Bayer AG
- Chiesi
- Phillips-Medisize
- Johnson & Johnson
- Shandong Weigao
- Pfizer
- B.Braun
- Novartis AG
- Zhengkang
- Gerresheimer
- COVIDIEN Medtronic
- Schott forma vitrum
- Alkermes
- Skyepharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Drug Delivery Devices Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Drug Delivery Devices Market Size by Region (2021-2032)
- 1.4.1 Global Drug Delivery Devices Market Size by Region (2021-2026)
- 1.4.2 Global Drug Delivery Devices Market Size by Region (2027-2032)
- 1.5 Key Regions Drug Delivery Devices Market Size (2021-2032)
- 1.5.1 North America Drug Delivery Devices Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Drug Delivery Devices Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Drug Delivery Devices Market Size Growth Rate (2021-2032)
- 1.5.4 South America Drug Delivery Devices Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Drug Delivery Devices Market Size Growth Rate (2021-2032)
2 Drug Delivery Devices Market by Type
- 2.1 Type Introduction
- 2.1.1 Injection Type
- 2.1.2 Mucosal Type
- 2.1.3 Implanted Type
- 2.1.4 Others Type
- 2.2 Global Drug Delivery Devices Market Size by Type
- 2.2.1 Global Drug Delivery Devices Market Size Overview by Type (2021-2032)
- 2.2.2 Global Drug Delivery Devices Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Drug Delivery Devices Market Size Forecasted by Type (2027-2032)
- 2.3 Global Drug Delivery Devices Market Size by Regions
- 2.3.1 North America Drug Delivery Devices Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Drug Delivery Devices Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Drug Delivery Devices Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Drug Delivery Devices Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Drug Delivery Devices Market Size Breakdown by Type (2021-2026)
3 Drug Delivery Devices Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical Companies
- 3.1.2 Hospitals
- 3.1.3 Clinics
- 3.1.4 Other
- 3.2 Global Drug Delivery Devices Market Size by Application
- 3.2.1 Global Drug Delivery Devices Market Size Overview by Application (2021-2032)
- 3.2.2 Global Drug Delivery Devices Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Drug Delivery Devices Market Size Forecasted by Application (2027-2032)
- 3.3 Global Drug Delivery Devices Market Size by Regions
- 3.3.1 North America Drug Delivery Devices Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Drug Delivery Devices Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Drug Delivery Devices Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Drug Delivery Devices Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Drug Delivery Devices Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Drug Delivery Devices Industry Trends
- 4.2 Drug Delivery Devices Industry Drivers
- 4.3 Drug Delivery Devices Industry Opportunities and Challenges
- 4.4 Drug Delivery Devices Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Drug Delivery Devices Revenue (2021-2026)
- 5.2 Global Drug Delivery Devices Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Drug Delivery Devices Key Company Headquarters & Area Served
- 5.4 Global Drug Delivery Devices Company, Product Type & Application
- 5.5 Global Drug Delivery Devices Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Drug Delivery Devices Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Drug Delivery Devices Players Market Share by Revenue in 2025
- 5.6.3 2025 Drug Delivery Devices Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Cipla
- 6.1.1 Cipla Company Information
- 6.1.2 Cipla Business Overview
- 6.1.3 Cipla Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Cipla Drug Delivery Devices Product Portfolio
- 6.1.5 Cipla Recent Developments
- 6.2 Baxter International
- 6.2.1 Baxter International Company Information
- 6.2.2 Baxter International Business Overview
- 6.2.3 Baxter International Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Baxter International Drug Delivery Devices Product Portfolio
- 6.2.5 Baxter International Recent Developments
- 6.3 Nipro Corporation
- 6.3.1 Nipro Corporation Company Information
- 6.3.2 Nipro Corporation Business Overview
- 6.3.3 Nipro Corporation Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Nipro Corporation Drug Delivery Devices Product Portfolio
- 6.3.5 Nipro Corporation Recent Developments
- 6.4 Roche
- 6.4.1 Roche Company Information
- 6.4.2 Roche Business Overview
- 6.4.3 Roche Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Roche Drug Delivery Devices Product Portfolio
- 6.4.5 Roche Recent Developments
- 6.5 Boehringer Ingelheim
- 6.5.1 Boehringer Ingelheim Company Information
- 6.5.2 Boehringer Ingelheim Business Overview
- 6.5.3 Boehringer Ingelheim Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Boehringer Ingelheim Drug Delivery Devices Product Portfolio
- 6.5.5 Boehringer Ingelheim Recent Developments
- 6.6 Allergan
- 6.6.1 Allergan Company Information
- 6.6.2 Allergan Business Overview
- 6.6.3 Allergan Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Allergan Drug Delivery Devices Product Portfolio
- 6.6.5 Allergan Recent Developments
- 6.7 3M
- 6.7.1 3M Company Information
- 6.7.2 3M Business Overview
- 6.7.3 3M Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 3M Drug Delivery Devices Product Portfolio
- 6.7.5 3M Recent Developments
- 6.8 BD
- 6.8.1 BD Company Information
- 6.8.2 BD Business Overview
- 6.8.3 BD Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 BD Drug Delivery Devices Product Portfolio
- 6.8.5 BD Recent Developments
- 6.9 Catalent
- 6.9.1 Catalent Company Information
- 6.9.2 Catalent Business Overview
- 6.9.3 Catalent Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Catalent Drug Delivery Devices Product Portfolio
- 6.9.5 Catalent Recent Developments
- 6.10 Valeant Pharmaceuticals
- 6.10.1 Valeant Pharmaceuticals Company Information
- 6.10.2 Valeant Pharmaceuticals Business Overview
- 6.10.3 Valeant Pharmaceuticals Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Valeant Pharmaceuticals Drug Delivery Devices Product Portfolio
- 6.10.5 Valeant Pharmaceuticals Recent Developments
- 6.11 Bayer AG
- 6.11.1 Bayer AG Company Information
- 6.11.2 Bayer AG Business Overview
- 6.11.3 Bayer AG Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Bayer AG Drug Delivery Devices Product Portfolio
- 6.11.5 Bayer AG Recent Developments
- 6.12 Chiesi
- 6.12.1 Chiesi Company Information
- 6.12.2 Chiesi Business Overview
- 6.12.3 Chiesi Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Chiesi Drug Delivery Devices Product Portfolio
- 6.12.5 Chiesi Recent Developments
- 6.13 Phillips-Medisize
- 6.13.1 Phillips-Medisize Company Information
- 6.13.2 Phillips-Medisize Business Overview
- 6.13.3 Phillips-Medisize Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Phillips-Medisize Drug Delivery Devices Product Portfolio
- 6.13.5 Phillips-Medisize Recent Developments
- 6.14 Johnson & Johnson
- 6.14.1 Johnson & Johnson Company Information
- 6.14.2 Johnson & Johnson Business Overview
- 6.14.3 Johnson & Johnson Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Johnson & Johnson Drug Delivery Devices Product Portfolio
- 6.14.5 Johnson & Johnson Recent Developments
- 6.15 Shandong Weigao
- 6.15.1 Shandong Weigao Company Information
- 6.15.2 Shandong Weigao Business Overview
- 6.15.3 Shandong Weigao Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Shandong Weigao Drug Delivery Devices Product Portfolio
- 6.15.5 Shandong Weigao Recent Developments
- 6.16 Pfizer
- 6.16.1 Pfizer Company Information
- 6.16.2 Pfizer Business Overview
- 6.16.3 Pfizer Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Pfizer Drug Delivery Devices Product Portfolio
- 6.16.5 Pfizer Recent Developments
- 6.17 B.Braun
- 6.17.1 B.Braun Company Information
- 6.17.2 B.Braun Business Overview
- 6.17.3 B.Braun Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 B.Braun Drug Delivery Devices Product Portfolio
- 6.17.5 B.Braun Recent Developments
- 6.18 Novartis AG
- 6.18.1 Novartis AG Company Information
- 6.18.2 Novartis AG Business Overview
- 6.18.3 Novartis AG Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Novartis AG Drug Delivery Devices Product Portfolio
- 6.18.5 Novartis AG Recent Developments
- 6.19 Zhengkang
- 6.19.1 Zhengkang Company Information
- 6.19.2 Zhengkang Business Overview
- 6.19.3 Zhengkang Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Zhengkang Drug Delivery Devices Product Portfolio
- 6.19.5 Zhengkang Recent Developments
- 6.20 Gerresheimer
- 6.20.1 Gerresheimer Company Information
- 6.20.2 Gerresheimer Business Overview
- 6.20.3 Gerresheimer Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Gerresheimer Drug Delivery Devices Product Portfolio
- 6.20.5 Gerresheimer Recent Developments
- 6.21 COVIDIEN Medtronic
- 6.21.1 COVIDIEN Medtronic Company Information
- 6.21.2 COVIDIEN Medtronic Business Overview
- 6.21.3 COVIDIEN Medtronic Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 COVIDIEN Medtronic Drug Delivery Devices Product Portfolio
- 6.21.5 COVIDIEN Medtronic Recent Developments
- 6.22 Schott forma vitrum
- 6.22.1 Schott forma vitrum Company Information
- 6.22.2 Schott forma vitrum Business Overview
- 6.22.3 Schott forma vitrum Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 Schott forma vitrum Drug Delivery Devices Product Portfolio
- 6.22.5 Schott forma vitrum Recent Developments
- 6.23 Alkermes
- 6.23.1 Alkermes Company Information
- 6.23.2 Alkermes Business Overview
- 6.23.3 Alkermes Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Alkermes Drug Delivery Devices Product Portfolio
- 6.23.5 Alkermes Recent Developments
- 6.24 Skyepharma
- 6.24.1 Skyepharma Company Information
- 6.24.2 Skyepharma Business Overview
- 6.24.3 Skyepharma Drug Delivery Devices Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 Skyepharma Drug Delivery Devices Product Portfolio
- 6.24.5 Skyepharma Recent Developments
7 North America
- 7.1 North America Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Drug Delivery Devices Market Size by Country (2021-2026)
- 7.3 North America Drug Delivery Devices Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Drug Delivery Devices Market Size by Country (2021-2026)
- 8.3 Europe Drug Delivery Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Drug Delivery Devices Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Drug Delivery Devices Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Drug Delivery Devices Market Size by Country (2021-2026)
- 10.3 South America Drug Delivery Devices Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Drug Delivery Devices Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Drug Delivery Devices Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst